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Abstract 
Poor adherence to treatment of chronic diseases is a worldwide problem of striking magnitude. Adherence to 
long-term therapy for chronic illnesses in developed countries averages 50%. Poor adherence to recognized 
standards of diabetes care is the principal cause of development of complications of diabetes and their associated 
individual, societal and economic costs. Information on adherence to antidiabetic medications among Type 2 
diabetes patients in Ethiopia is scanty. This study therefore sought to assess antidiabetic medication adherence 
and its determinants among 322 ambulatory patients with Type 2 diabetes mellitus attending the diabetic clinic 
of Tikur Anbessa Specialized Hospital (TASH). It was a cross-sectional study conducted from 1 May-30 June 
2014. Assessment of adherence was performed based on patients’ response to the validated four-item Morisky 
instrument. Adherence rate to antidiabetic medications was found to be 66.8%. Younger age, increased number 
of prescribed medications and job type (being a farmer/daily laborer) were significantly associated with 
antidiabetic medication non-adherence. Most of the patients missed their medications because of forgetfulness. 
Taken together, the findings indicated that adherence to antidiabetic drugs was suboptimal which warrants the 
need for health care providers engaged in diabetic care to aggressively address the issue. 
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INTRODUCTION  
Diabetes mellitus (DM) is a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia 
with disturbances of carbohydrate, fat and protein metabolism, resulting from defects in insulin secretion, insulin 
action, or both (1). Complications of DM have become a major public health problem in all countries. Type-2 
diabetes is an increasing worldwide public health issue and the number is increasing in every country with 
80% of diabetic people living in low and middle income countries. About 4.36% (1.9 million) of the Ethiopian 
population is estimated to live with diabetes and the number of deaths attributed to diabetes reached 34,262 in 
2013 (2).  
In both developed and developing countries, non-adherence to medication remains a significant concern 
for health care providers as well as patients because of its adverse consequences on therapeutic outcomes. Poor 
adherence to diabetes treatment recommendations would lead to manifestation of micro- and macrovascular 
complications and increased health care costs (3,4). Accomplishment of treatment plans by patients with type 2 
diabetes are essential in order to ensure normal or near normal fasting and postprandial blood glucose levels 
necessary for adequate control of diabetes, and subsequent reduction in mortality and reduced risk of 
complications (5). However, the need to make patients adequately committed to take their medications regularly 
and appropriately as well as adjusting their long standing lifestyles is among the most common challenges 
encountered by physicians and other healthcare providers involved in diabetes care (6). Assessment of the 
reasons for lack of adequate treatment adherence therefore is important before embarking on specific 
interventions that may fail, if specific regimen barriers are not identified.  
To the best of our knowledge, evidence-based research on antidiabetic medication adherence among 
type 2 diabetes patients in Ethiopia is scanty. The present study was therefore carried out with the objective of 
assessing the rate of antidiabetic medication adherence and factors associated with poor medication adherence 
together with reasons for non-adherence among ambulatory type 2 diabetic patients in Tikur Anbessa 
Specialized Hospital (TASH), Ethiopia. The findings would have contribution to the existing body of knowledge 
in the area and improve medication adherence through identifying areas of intervention. 
 
METHODS AND MATERIALS 
The study was conducted in the Diabetes Clinic of TASH. TASH is a 600-bed, tertiary level and the largest 
general public hospital in Ethiopia. The hospital is located in Addis Ababa and affiliated with College of Health 
Sciences of Addis Ababa University (AAU). A cross sectional study was conducted using patient interview 
which was conducted from 1st of May to 30th of June, 2014. The sample size calculated using single population 
proportion formula was 385. As the actual number of source population in the study period was 120, the 
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corrected sample size, using a correction formula was 292; a 10% contingency yielded a final sample size of 322. 
Systematic random sampling method was used to recruit samples for the study. All patients with type 2 diabetes 
and on treatment with antidiabetic drugs at least for 3 months, who were ≥18 years of age and who understood 
Amharic  language were included in the study. A Morisky Adherence Predictor Scale-4 item (MAPS-4) was 
utilized to collect information necessary to assess medication adherence. Patients who scored  ≤ 1 to the Morisky 
instrument were regarded as adherent to their antidiabetic medications. The data collection instrument was 
assessed by an expert in the field of endocrinology. In addition, pre-testing of the instrument was done among 
5% of randomly selected, type 2 diabetes patients, who were not included in the study, ahead of the start of the 
main data collection.  
The collected data was entered into Epi Info v-3.5.3 and analyzed using SPSS v-21. Descriptive 
statistics including: frequency, mean and standard deviation was used to summarize patients’ baseline socio-
demographic data and evaluate distribution of responses. Crude and Adjusted Odds Ratio (COR/ AOR) were 
calculated and 95% confidence level was used to determine factors associated with antidiabetic medications 
adherence. A p-value of 0.05 or less was considered statistically significant. Ethical clearance and approval of 
the study protocols was granted from the Ethical Review Board of School of Pharmacy, AAU. Prior to data 
collection, individual informed verbal consent was obtained from the study patients.  
 
RESULTS  
Socio-demographic Characteristics 
Females comprised 59.3% of the sex category. Majority of the patients were in the age group of 51-60 years, 
which accounted for 30.7%. The mean age of the studied population was 52.68 (SD=11.17) years (range 18 to 82 
years). Being a House wife (98, 30.4%) accounted for the highest percentage of occupation. Patients with higher 
education (94, 29.2%) constituted the highest percentage of educational status category (Table 1).  
Table 1: Socio-demographic characteristic of patients with type 2 diabetes attending the diabetic clinic of Tikur 
Anbessa specialized hospital. 
Variables Frequency  Percent  
Sex  
Male  
Female  
 
                       131 
191 
 
                                   40.7 
59.3 
Age (Years) 
≤40 
41-50 
51-60 
61-70 
>70 
 
                         51 
93 
99 
58 
21 
 
                                   15.8 
28.9 
30.7 
18.0 
6.5 
Marital Status 
Single  
Married  
Divorced  
Widowed 
 
                         42 
194 
39 
47 
 
                      13.0 
60.2 
12.1 
14.6 
Occupation  
House Wife  
Gov’t Employee 
Retired 
Merchant/Trade 
Unemployed  
Farmer 
Daily Laborer 
Others*  
 
                         98 
62 
54 
48 
19 
10 
7 
24 
 
                      30.4 
19.3 
16.8 
14.9 
5.9 
3.1 
2.2 
7.5 
Educational Status  
Cannot Read and Write 
Primary  
Secondary  
Higher Education 
 
                         70 
91 
67 
94 
 
                      21.7 
28.3 
20.8 
29.2 
*Carpenter, Construction, Driver, Garage (mechanic), Guard, Metal Work, Teacher working in private school 
Rate of Antidiabetic Medication Adherence and Reasons for Non-adherence 
Assessment of patients’ responses to the 4-item Morisky adherence predictor scale showed that 215 (66.8%) 
patients were adherent to the prescribed regimen of their antidiabetic medications (Table 2).  
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Table 2: Summary of type 2 diabetic patients’ responses to the 4-item Morisky Instrument, diabetic clinic of 
Tikur Anbessa specialized hospital. 
 
Question 
        Frequency (%) 
       Response 
Yes (1)                   No (0) 
1. Do you ever forget to take your antidiabetic medication 
(s)? 
2. Do you sometimes, not being careful in taking your 
medication (s)? 
3. When you feel better, do you sometimes stop taking your 
antidiabetic medication (s)? 
4. Sometimes if you feel worse when you take your 
antidiabetic medication (s), do you stop taking them? 
 
135(41.9)           187(58.1)              
 
                               155( 48.1)              167(51.9) 
 
           28(8.7)               294(91.3) 
 
          9(2.8)                 313(97.2) 
Distribution of scores  
0 
1 
2 
3 
4 
Total (%)           
123(38.2)                            
92(28.6)                              
87(27.0)                              
19(5.9)                                
1(0.3)                                  
Cut off Frequency (%) Category 
≤1 
>1 
 215 (66.8) 
107 (33.2) 
Adherent Non-adherent   
Up on evaluation of the reasons for antidiabetic medication non-adherence, it was identified that 100 
(93.5%) patients mentioned forgetfulness as the reason for their non-adherence. For each of 29 (27.1%) and 26 
(24.3%) patients, experiencing side effects and feeling well without treatment were the reasons for antidiabetic 
medication non-adherence, respectively. Others included busyness, fasting, sleeping and lack of access to 
medications (Figure 1). 
    
Figure 1:  Reasons for antidiabetic medication non-adherence among type 2 diabetic patients attending the 
diabetic clinic of Tikur Anbessa specialized hospital. 
Factors Associated with Antidiabetic Medication adherence  
After controlling different demographic, economical and other factors through the use of multivariate logistic 
regression analysis, this study showed that only age, occupation and total number of prescribed drugs had 
significant association with antidiabetic medication adherence (Table 5). 
 
DISCUSSION 
In the present study, adherence to antidiabetic medications was observed in 66.8% of the studied population. 
Similar studies conducted in Nigeria reported a prevalence rate of 60% (7) and 72.5% (5), to which the present 
study was relatively comparable with. The prevalence was greater than the result found in Malaysia 47% (8), 
India 16.6% (6), and US-Mexico Border 40% (9). However, it was lower than the prevalence found in the 
Brazilian study 78.3% (10). Lower adherence rates to drug therapy for diabetes management is a matter of 
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concern as chronic complications due to poor glucose control are likely to increase with time. In the light of poor 
blood glucose control and alleged failure of therapeutic regimen, health providers are urged to measure diabetic 
patient treatment adherence. When accurate and clear information on the importance of medication adherence is 
provided, patients are encouraged towards self-care and adherence to drug therapy.  
Table 5: Multivariate logistic regression analysis result of factors associated with antidiabetic medication non-
adherence among type 2 diabetic patients attending the diabetic clinic of Tikur Anbessa specialized 
hospital. 
Variables Adherence COR , 95 % CI AOR, 95% CI 
No (%) Yes (%) 
Age Category 
≤40 
41-50 
51-60 
61-70 
≥71 
 
20(39.2) 
31(33.3) 
27(27.3) 
20(34.5) 
9(42.9) 
 
31(60.8) 
62(66.7) 
72(72.7) 
38(65.5) 
12(57.1) 
 
1.00 
1.29(0.64, 2.62) 
1.72(0.84, 3.52) 
1.23(0.56, 2.68) 
0.86(0.31, 2.41) 
 
1.00 
1.97(0.86, 4.51) 
2.93(1.23, 6.98)* 
2.11(0.75, 5.90) 
1.54(0.42, 5.61) 
Educational Status 
Cannot Read and Write 
Primary 
Secondary 
Higher Education 
 
31(44.3) 
29(31.9) 
25(37.3) 
22(23.4) 
 
39(55.7) 
62(68.1) 
42(62.7) 
72(76.6) 
 
1.00 
1.70(0.89, 3.24) 
1.34(0.67, 2.65) 
2.61(1.33, 5.09) 
* 
 
1.00 
1.24(0.58, 2.63) 
0.93(0.40, 2.18) 
1.12(0.43, 2.96) 
Occupation  
Farmer/Daily Laborer 
Gov’t Employee 
Merchant 
House Wife 
Retired 
Unemployed 
Other Occupation  
 
10(58.8) 
13(21.0) 
15(31.3) 
35(35.7) 
18(33.3) 
6(31.6) 
10(41.7) 
 
7(41.2) 
49(79.0) 
33(68.8) 
63(64.3) 
36(66.7) 
13(68.4) 
14(58.3) 
 
1.00 
5.39(1.72, 
16.89)* 
3.14(1.00, 
9.85)* 
2.57(0.90, 7.35) 
2.86(0.93, 8.75) 
3.10(0.79, 
12.14) 
2.00(0.57, 7.06) 
 
1.00 
5.89(1.34, 24.95)* 
3.76(0.90, 15.68) 
3.46(0.97, 12.35) 
3.55(0.81, 15.64) 
4.85(0.89, 26.40) 
2.35(0.52, 10.68) 
Family Income Category 
Very Low 
Low 
Average 
Above Average 
High  
 
36(36.4) 
45(40.9) 
11(18.97) 
5(25) 
10(28.6) 
 
63(63.6) 
65(59.1) 
47(81.03) 
15(75) 
25(71.4) 
 
1.00 
0.86(0.47, 1.44) 
2.19(1.03, 4.66) 
* 
2.29(0.71, 7.36) 
1.43(0.62, 3.31) 
 
1.00 
0.83(0.42, 1.63) 
1.71(0.67, 4.37) 
1.50(0.36, 6.23) 
1.08(0.35, 3.33) 
Presence of Glucometer 
No 
Yes 
 
69(39.7) 
38(25.7) 
 
105(60.3) 
110(74.3) 
 
1.00 
1.90(1.18, 
3.07)* 
 
1.00 
1.60(0.90, 2.84) 
Total Number of Drugs 
1 
2 
3 
4 
5 
>5 
 
5(17.2) 
25(31.3) 
18(34.0) 
24(32.9) 
15(33.3) 
20(40.6) 
 
24(82.8) 
55(68.8) 
35(66.0) 
49(67.1) 
30(66.7) 
22(52.4) 
 
1.00 
0.46(0.16, 1.34) 
0.41(0.13, 1.24) 
0.43(0.14, 1.25) 
0.42(0.13, 1.31) 
0.23(0.07, 
0.72)* 
 
1.00 
0.31(0.09, 1.04) 
0.23(0.06, 0.84)* 
0.25(0.07, 0.92)* 
0.25(0.07, 0.94)* 
0.12(0.03, 0.44)* 
Overall Exercise Adherence 
No 
Yes 
 
93(35.8) 
14(22.6) 
 
167(64.2) 
48(77.4) 
 
1.00 
1.91(1.00, 
3.65)* 
 
1.00 
1.82(0.90, 3.66) 
*Statistically Significant: P ≤ 0.05 
In this study, older patients were more likely to adhere to their antidiabetic medications compared to 
younger patients. This result was consistent with studies conducted  among  diabetic  patients  in  different 
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corners of the globe (8,11–15). It  is  possible  that   younger  patients  were less  aware  of  their  disease  and  
were  thus  more  likely  to be more non-adherent. On the other hand, older patients showed better adherence 
since these people might have more severe form of the disease compared to the other age groups. This particular 
scenario observed in the present study emphasizes the need for educating the younger generation. Occupation 
was the other variable that had significant association with antidiabetic medication adherence in the present 
study. Patients who were government employees were more likely to engage in adherence compared to those 
who were farmers and daily laborers.  Here, it is also possible that farmers and daily laborers might be less aware 
of their disease and the importance of medication adherence when compared with governmental employees and 
thus more likely to be more non-adherent. On the other hand, as the number of prescribed drugs increased, 
patients were found to be less likely to adhere to their medications. A vast number of literatures support this 
finding which describe as pill burden negatively affects patient adherence to treatment(16–19). Drug regimen for 
patients with diabetes can become complex and adherence may definitely be a challenge for patients.  
In this study, patients with poor adherence reported several reasons for not adhering to antidiabetic 
medications. The most common reasons were found to be forgetfulness, experiencing side effects and feeling of 
being well without treatment. Most of the patients missed  their  antidiabetic  medications  due  to forgetfulness  
which  is  similar  to  that  reported  in other studies (9,17,20–22). Adherence to therapies is a primary 
determinant of treatment success. Failure to adherence is a serious problem, which not only affects the patient 
but also the health care system. It leads to substantial worsening of disease, death and increased health care costs. 
Identifying specific barriers for each patient and adopting suitable techniques to overcome them will be 
necessary to improve medication adherence.  
 
CONCLUSIONS  
Overall, the findings from the present study indicated that the antidiabetic medication adherence of ambulatory 
type 2 diabetes patients in TASH is suboptimal (66.8%). Socio-economic status and pill burden had an important 
role in deciding adherence rate. Younger age, increased number of prescribed drugs and job being a farmer/daily 
laborer were significantly associated with non-adherence. Forgetfulness was the most important reason 
preventing optimal adherence to prescribed medications.  
 
RECOMMENDATIONS 
Since adherence in the present study was below that of recommended in the literature and in the light of poor 
blood glucose control, health providers who are engaged in diabetic care are urged to measure diabetic patient 
treatment adherence, because it is key to adequate diabetes management with drugs. They also should make 
every  effort  to  assist  patients  who  wish  to  do  so  to  improve  adherence  to  their treatments. Prospective 
studies with multiple methods of adherence assessment, involving pill count and biological assay may be 
required to detect patient who report adherence but who may in fact be non-adherent to antidiabetic medications. 
Mechanisms have to be devised to minimize forgetfulness which was reported as the main reason for antidiabetic 
medication non-adherence.  
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